Cargando…
Roux‐en‐Y gastric bypass surgery alters serum metabolites and fatty acids in patients with morbid obesity
AIM: Bariatric surgery induces significant weight loss, increases insulin sensitivity, and reduces mortality, but the underlying mechanisms are not clear. It was hypothesized that Roux‐en‐Y gastric bypass (RYGB) surgery improves metabolic profile along with weight loss. The objective of this pilot s...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238211/ https://www.ncbi.nlm.nih.gov/pubmed/30003682 http://dx.doi.org/10.1002/dmrr.3045 |
_version_ | 1783371327957106688 |
---|---|
author | Wijayatunga, Nadeeja N. Sams, Valerie G. Dawson, John A. Mancini, Matthew L. Mancini, Gregory J. Moustaid‐Moussa, Naima |
author_facet | Wijayatunga, Nadeeja N. Sams, Valerie G. Dawson, John A. Mancini, Matthew L. Mancini, Gregory J. Moustaid‐Moussa, Naima |
author_sort | Wijayatunga, Nadeeja N. |
collection | PubMed |
description | AIM: Bariatric surgery induces significant weight loss, increases insulin sensitivity, and reduces mortality, but the underlying mechanisms are not clear. It was hypothesized that Roux‐en‐Y gastric bypass (RYGB) surgery improves metabolic profile along with weight loss. The objective of this pilot study was to evaluate changes in serum metabolites and fatty acids (FA) at 2 weeks and 6 months after RYGB. MATERIALS AND METHODS: Serum samples were collected pre‐surgery, at 2 weeks and 6 months post‐surgery from 20 patients undergoing RYGB surgery. Serum non‐esterified free FA (NEFA) were measured. Serum metabolites and FA were measured using nuclear magnetic resonance spectroscopy and improved direct fatty acid methyl ester synthesis and the gas chromatography/mass spectrometry method, respectively, in subjects who completed follow‐up at 6 months (n = 8). RESULTS: Mean (standard deviation) percent total weight loss was 6.70% (1.7) and 24.91% (6.63) at 2 weeks (n = 15) and 6 months (n = 8) post‐surgery, respectively. NEFA were significantly reduced at 6 months post‐surgery (P = 0.001, n = 8). Serum branched chain amino acids, 2‐aminobutyrate, butyrate, 2‐hydroxybutyrate, 3‐hydroxybutyrate, acetone, 2‐methylglutarate, and 2‐oxoisocaproate were significantly reduced, while serum alanine, glycine, pyruvate, and taurine were significantly elevated at 6 months post‐surgery compared with pre‐surgery (n = 8, P < 0.05). Also, serum FA C10:0, C13:0, C14:0, C15:0, and C18:0 increased significantly (n = 8, P < 0.05) by 6 months post‐surgery. CONCLUSIONS: Changes in serum metabolites and FA at 6 months post‐RYGB surgery in this pilot study with limited number of participants are suggestive of metabolic improvement; larger studies are warranted for confirmation. |
format | Online Article Text |
id | pubmed-6238211 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-62382112018-12-14 Roux‐en‐Y gastric bypass surgery alters serum metabolites and fatty acids in patients with morbid obesity Wijayatunga, Nadeeja N. Sams, Valerie G. Dawson, John A. Mancini, Matthew L. Mancini, Gregory J. Moustaid‐Moussa, Naima Diabetes Metab Res Rev Research Articles AIM: Bariatric surgery induces significant weight loss, increases insulin sensitivity, and reduces mortality, but the underlying mechanisms are not clear. It was hypothesized that Roux‐en‐Y gastric bypass (RYGB) surgery improves metabolic profile along with weight loss. The objective of this pilot study was to evaluate changes in serum metabolites and fatty acids (FA) at 2 weeks and 6 months after RYGB. MATERIALS AND METHODS: Serum samples were collected pre‐surgery, at 2 weeks and 6 months post‐surgery from 20 patients undergoing RYGB surgery. Serum non‐esterified free FA (NEFA) were measured. Serum metabolites and FA were measured using nuclear magnetic resonance spectroscopy and improved direct fatty acid methyl ester synthesis and the gas chromatography/mass spectrometry method, respectively, in subjects who completed follow‐up at 6 months (n = 8). RESULTS: Mean (standard deviation) percent total weight loss was 6.70% (1.7) and 24.91% (6.63) at 2 weeks (n = 15) and 6 months (n = 8) post‐surgery, respectively. NEFA were significantly reduced at 6 months post‐surgery (P = 0.001, n = 8). Serum branched chain amino acids, 2‐aminobutyrate, butyrate, 2‐hydroxybutyrate, 3‐hydroxybutyrate, acetone, 2‐methylglutarate, and 2‐oxoisocaproate were significantly reduced, while serum alanine, glycine, pyruvate, and taurine were significantly elevated at 6 months post‐surgery compared with pre‐surgery (n = 8, P < 0.05). Also, serum FA C10:0, C13:0, C14:0, C15:0, and C18:0 increased significantly (n = 8, P < 0.05) by 6 months post‐surgery. CONCLUSIONS: Changes in serum metabolites and FA at 6 months post‐RYGB surgery in this pilot study with limited number of participants are suggestive of metabolic improvement; larger studies are warranted for confirmation. John Wiley and Sons Inc. 2018-09-19 2018-11 /pmc/articles/PMC6238211/ /pubmed/30003682 http://dx.doi.org/10.1002/dmrr.3045 Text en © 2018 The Authors. Diabetes/Metabolism Research and Reviews published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Articles Wijayatunga, Nadeeja N. Sams, Valerie G. Dawson, John A. Mancini, Matthew L. Mancini, Gregory J. Moustaid‐Moussa, Naima Roux‐en‐Y gastric bypass surgery alters serum metabolites and fatty acids in patients with morbid obesity |
title | Roux‐en‐Y gastric bypass surgery alters serum metabolites and fatty acids in patients with morbid obesity |
title_full | Roux‐en‐Y gastric bypass surgery alters serum metabolites and fatty acids in patients with morbid obesity |
title_fullStr | Roux‐en‐Y gastric bypass surgery alters serum metabolites and fatty acids in patients with morbid obesity |
title_full_unstemmed | Roux‐en‐Y gastric bypass surgery alters serum metabolites and fatty acids in patients with morbid obesity |
title_short | Roux‐en‐Y gastric bypass surgery alters serum metabolites and fatty acids in patients with morbid obesity |
title_sort | roux‐en‐y gastric bypass surgery alters serum metabolites and fatty acids in patients with morbid obesity |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238211/ https://www.ncbi.nlm.nih.gov/pubmed/30003682 http://dx.doi.org/10.1002/dmrr.3045 |
work_keys_str_mv | AT wijayatunganadeejan rouxenygastricbypasssurgeryaltersserummetabolitesandfattyacidsinpatientswithmorbidobesity AT samsvalerieg rouxenygastricbypasssurgeryaltersserummetabolitesandfattyacidsinpatientswithmorbidobesity AT dawsonjohna rouxenygastricbypasssurgeryaltersserummetabolitesandfattyacidsinpatientswithmorbidobesity AT mancinimatthewl rouxenygastricbypasssurgeryaltersserummetabolitesandfattyacidsinpatientswithmorbidobesity AT mancinigregoryj rouxenygastricbypasssurgeryaltersserummetabolitesandfattyacidsinpatientswithmorbidobesity AT moustaidmoussanaima rouxenygastricbypasssurgeryaltersserummetabolitesandfattyacidsinpatientswithmorbidobesity |